- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Biocon Limited — Updates, 18-09-2025: Press Release
18-09-2025 | 04:24 pm
18-09-2025 | 04:24 pm
Biocon Biologics' Yesafili® (aflibercept) secures public funding in Ontario, Canada, for retinal diseases. This boosts market access for their seventh biosimilar, promising broader patient reach and potential revenue growth.
No comments yet. Be the first to comment!